Both Novo Nord's Dual GIP/GLP-1 and copyright are modern medications intended for treating hyperglycemia and supporting weight reduction . However, they function through distinct pathways. Semaglutide is a GLP-1 receptor area agonist , while Zepotide acts as a dual GIP and GLP-1 activator , possi